| Display title | Efgartigimod alfa/hyaluronidase |
| Default sort key | Efgartigimod alfa hyaluronidase |
| Page length (in bytes) | 4,767 |
| Namespace ID | 0 |
| Page ID | 74121221 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of page watchers | Fewer than 30 watchers |
| Number of redirects to this page | 2 |
| Counted as a content page | Yes |
| Wikidata item ID | Q120487796 |
| Local description | Combination medication |
| Central description | combination medication |
| Page views in the past 30 days | |
| Edit | Allow all users (no expiry set) |
| Move | Allow all users (no expiry set) |
| Page creator | Whywhenwhohow (talk | contribs) |
| Date of page creation | 18:51, 24 June 2023 |
| Latest editor | Pashihiko (talk | contribs) |
| Date of latest edit | 07:45, 29 September 2023 |
| Total number of edits | 8 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |
| Hidden categories (14) | This page is a member of 14 hidden categories (help):
|
| Transcluded templates (108) | Pages transcluded onto the current version of this page (help):
|
| Wikidata entities used in this page | |
